Taiwan Chondroitin Sulfate Market Size & Outlook
Taiwan chondroitin sulfate market, 2017-2030 (US$M)
Related Markets
Taiwan chondroitin sulfate market highlights
- The Taiwan chondroitin sulfate market generated a revenue of USD 24.7 million in 2022 and is expected to reach USD 32.5 million by 2030.
- The Taiwan market is expected to grow at a CAGR of 3.5% from 2023 to 2030.
- In terms of segment, bovine was the largest revenue generating source in 2022.
- Synthetic is the most lucrative source segment registering the fastest growth during the forecast period.
Chondroitin sulfate market data book summary
| Market revenue in 2022 | USD 24.7 million |
| Market revenue in 2030 | USD 32.5 million |
| Growth rate | 3.5% (CAGR from 2022 to 2030) |
| Largest segment | Bovine |
| Fastest growing segment | Synthetic |
| Historical data | 2017 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bovine, Swine, Poultry, Shark, Synthetic |
| Key market players worldwide | Merck KGaA, BRF SA ADR, Seikagaku, TSI Group, Bioiberica, Bio-gen Extracts |
Other key industry trends
- In terms of revenue, Taiwan accounted for 2.0% of the global chondroitin sulfate market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China chondroitin sulfate market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 91.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Chondroitin Sulfate Market Scope
Chondroitin Sulfate Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Taiwan chondroitin sulfate market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chondroitin sulfate market will help companies and investors design strategic landscapes.
Bovine was the largest segment with a revenue share of 38.06% in 2022. Horizon Databook has segmented the Taiwan chondroitin sulfate market based on bovine, swine, poultry, shark, synthetic covering the revenue growth of each sub-segment from 2017 to 2030.
Taiwan is a prominent supplier of chondroitin sulfate with glucosamine in Asia Pacific. In Taiwan, most of the chondroitin sulfate is derived from shark cartilages as it is used in several pharmaceutical products. These products are effective for the treatment of osteoarthritis and to provide relief from joint pain.
In addition, growing consumption of chondroitin sulfate in dietary supplements is anticipated to drive the market. However, the use of Lasonil N in pharmaceutical sector, which acts as a substitute to chondroitin sulfate can hamper the market growth.
Reasons to subscribe to Taiwan chondroitin sulfate market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Taiwan chondroitin sulfate market databook
-
Our clientele includes a mix of chondroitin sulfate market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Taiwan chondroitin sulfate market , including forecasts for subscribers. This country databook contains high-level insights into Taiwan chondroitin sulfate market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Taiwan chondroitin sulfate market size, by source, 2017-2030 (US$M)
Taiwan Chondroitin Sulfate Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
